Adtalem (ATGE) Q4 Revenue Jumps 12%
Adtalem Global Education (NYSE:ATGE), a major provider of healthcare-focused education, released its earnings for the fiscal fourth quarter of 2025 on August 7, 2025. Key highlights include a revenue figure of $457.1 million (GAAP), topping analyst expectations of $440.93 million, and an adjusted, non-GAAP earnings per share (EPS) of $1.66 versus a $1.53 estimate. Both revenue (GAAP) and profit (non-GAAP EPS) metrics exceeded consensus by 3.7% and 8.5%, respectively. Momentum in student enrollment, increased efficiency, and outperformance across the Walden and Chamberlain University segments powered this result. The quarter ended with a positive outlook, although margin compression at Chamberlain and capacity constraints in the Medical and Veterinary segment merit close attention as Adtalem moves forward.
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q3 2025 earnings report.
Adtalem Global Education is a leading U.S.-based provider of postsecondary education, specializing in healthcare through institutions such as Chamberlain University (nursing and health sciences), Walden University (graduate and doctoral programs with a large healthcare component), and its Medical and Veterinary segment. Its core strategy is to meet the growing national demand for educated healthcare professionals, while maintaining strict regulatory compliance and financial stability.
Source Fool.com
Adtalem Global Education Inc Stock
With 30 Buy predictions and 1 Sell predictions Adtalem Global Education Inc is one of the favorites of our community.
However, we have a potential of -88.6% for Adtalem Global Education Inc as the target price of 13 € is below the current price of 114.0 €.
